News | January 03, 2023
Blacksmith announces merger with Forge Therapeutics
To create leading company developing medicines targeting metalloenzymes
To create leading company developing medicines targeting metalloenzymes
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Having a healthy gut is key as it permits the body to build a stronger immune system
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
All claims against the company in the litigation have now been dismissed.
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Subscribe To Our Newsletter & Stay Updated
